Blackrock Neurotech

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Together, we’ve developed the most proven and versatile neurotechnology platform known to man - including the first chronically implanted, in-human brain-computer interface (BCI). We build implantable technology that changes lives, enabling BCI users to walk, talk, see, hear, and feel again.

As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications.

Our NeuroPort is the most powerful and tested BCI across the globe - interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used the NeuroPort for a collective 30,000+ days to regain freedom through movement and communication. In 2021, this array received a Breakthrough Designation from the FDA to start clinical trials.